alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31.b  CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002  I, Theodore Misiewicz, certify that:  1.
        I have reviewed this Form 10-KSB/A for the period ended September 30, 2005, of Morgan Beaumont, Inc. (the Company);  2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;  3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects our financial condition, results of operations and cash flows as of, and for, the periods presented in this report;  4.           Our other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in EXCHANGE ACT RULES 13a-15 and 15d-15) and have:  (a) Designed such disclosure controls and procedures to ensure that material information relating to us, including our consolidated subsidiaries, is made known to it by others within those entities, particularly during the period in which this report is being prepared;  (b) Evaluated the effectiveness of our disclosure controls and procedures as of a date within 90 days prior to the filing date of this report (the Evaluation Date); and  (c) Presented in this report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;  5.           Our other certifying officers and I have disclosed, based on our most recent evaluation, to our auditors and the audit committee of Companys board of directors (or persons performing the equivalent functions):  (a) All significant deficiencies in the design or operation of internal controls which could adversely affect our ability to record, process, summarize and report financial data and have identified for our auditors any material weaknesses in internal controls; and  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in our internal controls; and        6.           Our other certifying officers and I have indicated in this report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.   /S/ THEODORE MISIEWICZDate: June 2, 2006
        Theodore Misiewicz
Chief Financial Officer, Secretary and Director   * Provide a separate certification for each principal executive officer and principal financial officer of the Company. See Rules 13a-14(a) and 15d-14(a).
(85 South. 921)

#### Ex parte FORBES.

(7 Div. 90.)

(Supreme Court of Alabama.

May 20, 1920.)

Certiorari to Court of Appeals.

Harvey A. Emerson, of Anniston, for appellant.

J. Q. Smith, Atty. Gen., for appellee.

GARDNER, J.

Petition of Wesley Porbes for certiorari to the Court of Appeals to review and revise the judgment of said court affirming the decision of the lower court on the appeal in Ex parte Wesley Forbes, 85 South. 590. Writ denied.
```

[Federal Register Volume 66, Number 79 (Tuesday, April 24, 2001)]
[Notices]
[Pages 20659-20660]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-10018]

=======================================================================
-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM

Change in Bank Control Notices; Acquisition of Shares of Bank or 
Bank Holding Companies

    The notificants listed below have applied under the Change in Bank 
Control Act (12 U.S.C. 1817(j)) and Sec. 225.41 of the Board's 
Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. 
The factors that are considered in acting on the notices are set forth 
in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).
    The notices are available for immediate inspection at the Federal 
Reserve Bank indicated. The notices also will be available for 
inspection at the office of the Board of Governors. Interested persons 
may express their views in writing to the Reserve Bank

[[Page 20660]]

indicated for that notice or to the offices of the Board of Governors. 
Comments must be received not later than May 8, 2001.
    A. Federal Reserve Bank of Minneapolis (JoAnne F. Lewellen, 
Assistant Vice President) 90 Hennepin Avenue, Minneapolis, Minnesota 
55480-0291:
    1. Aaron D. Levorsen, Elgin, North Dakota; to acquire voting shares 
of Elgin Bancshares, Inc., Elgin, North Dakota and thereby indirectly 
acquire shares of Farmers State Bank, Elgin, North Dakota.
    B. Federal Reserve Bank of San Francisco (Maria Villanueva, 
Consumer Regulation Group) 101 Market Street, San Francisco, California 
94105-1579:
    1. Peter Eliades, Las Vegas, Nevada; to retain voting shares of 
Business Bank Corp., Las Vegas, Nevada, and thereby indirectly retain 
voting shares of Business Bank of Nevada, Las Vegas, Nevada.

    Board of Governors of the Federal Reserve System, April 18, 
2001.
Robert deV. Frierson
Associate Secretary of the Board.
[FR Doc. 01-10018 Filed 4-23-01; 8:45 am]
BILLING CODE 6210-01-S
```
ohrp_ex1016.htm


     

    
      Exhibit 10.16

       

      Ohr
Pharmaceutical, Inc

      1245
Brickyard Road, #590

      Salt lake
City, Utah 84106

      801-433-2000
ph

      801-433-2222
fx

    

     

    February
25, 2010

    


    Dr. Irach
Taraporewala

    9009 N Fm
620

    Austin,
TX 78726

     

    Dear
Irach:

    


    On behalf
of Ohr Pharmaceutical Inc., I am pleased to offer you employment as Chief
Executive Officer for Ohr, reporting to the Board of Directors.  Your
base salary will be at a bi-weekly rate of $5000.00 which is annualized at a
rate of $130,000.  Your start date will be Monday, April 12,
2010

     

    You will
be granted incentive stock options to purchase 800,000 shares of Ohr common
stock at $0.50, 400,000 options will vest immediately upon your employment and
the rest will vest on an annual basis of 100,000 options per installment whole
employed at Ohr.

     

    Your
employment will renew automatically on an annual basis. This is the full and
complete agreement between us on this term.  This provision can only
be modified in writing signed by both you and an officer of the
Company.

     

    Your
employment pursuant to this offer is contingent on you signing a Proprietary
Information and Inventions Agreement, covering the ownership of any intellectual
property developed by you and confidentiality obligations. 

     

    We very
much hope that you will accept our offer and look forward to having you on the
team.

     

    Sincerely
yours,

     

    Andrew
Limpert

    Interim
CEO

    


    I accept
the offer of employment above.

     

    
       

        
          

        

      

    

    Name                                                                                                                                                                                                                     
Date
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-25-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                             247
<SECURITIES>                                        12
<RECEIVABLES>                                      464
<ALLOWANCES>                                         4
<INVENTORY>                                          0
<CURRENT-ASSETS>                                  1116
<PP&E>                                             720
<DEPRECIATION>                                     484
<TOTAL-ASSETS>                                    1455
<CURRENT-LIABILITIES>                              638
<BONDS>                                             13
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                         720
<TOTAL-LIABILITY-AND-EQUITY>                      1455
<SALES>                                           1775
<TOTAL-REVENUES>                                  1775
<CGS>                                             1659
<TOTAL-COSTS>                                     1659
<OTHER-EXPENSES>                                    75
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   1
<INCOME-PRETAX>                                     78
<INCOME-TAX>                                        31
<INCOME-CONTINUING>                                 47
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                        47
<EPS-BASIC>                                       1.39
<EPS-DILUTED>                                     1.36


</TABLE>
Exhibit 32

                 CERTIFICATE PURSUANT TO 18 U.S.C. SECTION 1350,
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Advanced Technologies Group, Ltd. (the
"Company") on Form 10-KSB for the fiscal year ended January 31, 2007 as filed
with the Securities and Exchange Commission (the "Report"), each of the
undersigned, in the capacities and on the dates indicated below, hereby
certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

     1.   the Report fully complies with the requirements of Section 13(a)
          or15(d) of the Securities Exchange Act of 1934; and

     2.   the information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.


Dated: May 2, 2007           By: /s/ Abel Raskas
                                 -------------------------------
                                 Abel Raskas
                                 President


Dated: May 2, 2007           By: /s/ Alex Stelmak
                                 -------------------------------
                                 Alex Stelmak
                                 Chief Financial Officer
<PAGE>

                                                                  Exhibit 99.1

                                  CERTIFICATION





         Pursuant to section 906 of the  Sarbanes-Oxley Act of 2002 (subsections
(a) and (b) of section 1350,  chapter 63 of title 18, United States Code),  each
of the undersigned  officers of NovaDel Pharma Inc., a Delaware corporation (the
"Company"),  does hereby  certify,  to the best of such officer's  knowledge and
belief, that:


         (1) The  Quarterly  Report on Form 10-QSB for the quarter ended January
31, 2003 fully complies with the requirements of section 13 (a) or 15 (d) of the
Securities Exchange Act of 1934; and


         (2) The information  contained in the Form 10-QSB fairly  presents,  in
all material respects,  the financial condition and results of operations of the
Company.



Dated: March 10, 2003                        /s/ Gary A. Shangold, M.D.
       --------------                       -----------------------------------
                                                Gary A. Shangold, M.D.
                                            President & Chief Executive Officer


Dated: March 10, 2003                       /s/ Donald J. Deitman
       --------------                      ---------------------------------
                                               Donald J. Deitman
                                             Chief Financial Officer

<PAGE>
Argued and submitted January 25,

affirmed February 17, 1999

#### In the Matter of Frank Lee Banks, III, a Minor Child. STATE ex rel JUVENILE DEPARTMENT OF MULTNOMAH COUNTY, *Respondent, v.*FRANK LEE BANKS, II, *Appellant.*

(9302-80456; CA A103036)

974 P2d 792

Gary B. Bertoni filed the brief for appellant.

Katherine H. Waldo, Assistant Attorney General, argued the cause for respondent Juvenile Department of Multnomah County. With her on the brief were Hardy Myers, Attorney General, and Michael D. Reynolds, Solicitor General.

Kathryn Worden Underhill filed the brief for respondent child.

*453Before Landau, Presiding Judge, and Deits, Chief Judge, and Rossman, Senior Judge.

LANDAU, P. J.

*454LANDAU, P. J.

In this proceeding for termination of parental rights, father failed to appear at a scheduled mandatory pretrial conference. Father was represented by counsel, and counsel was present at the hearing. The trial court held father in default and permitted the state to proceed with a *prima facie*case for termination. Father’s counsel objected as follows:

> “I would raise the same objections that I have in other termination cases where there’s a parent that fails to appear regarding the ability of the State to proceed by *prima facie*and would — no further comments.”

The trial court proceeded with *the prima facie*hearing, at the conclusion of which it found that the state had proven its case by clear and convincing evidence and ordered termination of father’s parental rights. Several weeks later, father moved to set aside the termination. The trial court denied the motion. Father appeals.

On appeal, father assigns error to the trial court’s termination of parental rights without father being present at the hearing. Father raises a number of arguments, all to the effect that the trial court’s decision to proceed without father being present violated a number of statutory provisions as well as the due process clause of the Fourteenth Amendment to the United States Constitution. The state argues, among other things, that father’s arguments were not preserved. We agree with the state.

Father’s attorney interposed “the same objections that I have in other termination cases.” The record of this case, however, does not reflect what those objections were or whether the trial comí; understood what the objections were. Under the circumstances, we cannot regard father’s contentions on appeal as having been preserved. *See J. Arlie Bryant, Inc. v. Columbia River Gorge Comm.,*132 Or App 565, 568, 889 P2d 383, *rev den*321 Or 47 (1995) (preservation is required to give the trial court an opportunity to prevent error and to give opposing parties an opportunity to respond at the factfinding level of adjudication).

Affirmed.
EXHIBIT 32.1

                  CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND
                             CHIEF FINANCIAL OFFICER
                                   PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Annual Report on Form 10-KSB (the "Report") of
Intraop Medical Corporation (the "Company") for the year ended December 31,
2004, as filed with the Securities and Exchange Commission on the date hereof
(the "Report"), I, David Shamy, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

        (1) The Report fully complies with the requirements of section 13(a) or
    15(d) of the Securities Exchange Act of 1934; and

        (2) The information contained in the Report fairly presents, in all
    material respects, the financial condition and results of operations of the
    Company.

               By:  /s/ DAVID SHAMY
                   ---------------------------------------------
               David Shamy
               Chief Executive Officer/ President / Chief Financial Officer


March 8, 2005

A signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.


                                       24
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          AUG-28-1999
<PERIOD-START>                             AUG-30-1998
<PERIOD-END>                               FEB-27-1999
<CASH>                                          28,387
<SECURITIES>                                         0
<RECEIVABLES>                                    8,034
<ALLOWANCES>                                     (317)
<INVENTORY>                                     24,960
<CURRENT-ASSETS>                                63,783
<PP&E>                                          82,489
<DEPRECIATION>                                (34,781)
<TOTAL-ASSETS>                                 155,742
<CURRENT-LIABILITIES>                           24,881
<BONDS>                                        130,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   155,742
<SALES>                                        111,102
<TOTAL-REVENUES>                               111,102
<CGS>                                           40,310
<TOTAL-COSTS>                                   51,837
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               5,992
<INCOME-PRETAX>                                 13,433
<INCOME-TAX>                                       197
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    13,236
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 16-1766

MICHAEL MUNOZ,

Plaintiff - Appellant,

v.

SUNTRUST BANK,

Defendant - Appellee.

Appeal from the United States District Court for the Western 

District of North Carolina, at Statesville. Richard L. 

Voorhees, District Judge. (5:15-cv-00119-RLV-DCK)

Submitted: January 20, 2017 Decided: January 26, 2017

Before AGEE, WYNN, and HARRIS, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Michael Munoz, Appellant Pro Se. Matthew William Krueger-Andes, 

Robert R. Marcus, SMITH MOORE LEATHERWOOD LLP, Charlotte, North 

Carolina, for Appellee. 

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Michael Munoz appeals the district court’s order granting 

SunTrust Bank’s motion to dismiss and dismissing Munoz’s civil 

action for lack of prudential standing. We have reviewed the 

record and find no reversible error. Accordingly, we affirm for 

the reasons stated by the district court. Munoz v. SunTrust 

Bank, No. 5:15-cv-00119-RLV-DCK (W.D.N.C. June 3, 2016). We 

dispense with oral argument because the facts and legal 

contentions are adequately presented in the materials before 

this court and argument would not aid the decisional process.

AFFIRMED
# Explorar Mis Opciones

Consulte sus opciones con respecto a asuntos pendientes u opciones de inmigración que tal vez desee completar mientras visita nuestro sitio.****

06/01/2023

0 / 2000Para proteger su privacidad, por favor no incluya ninguna información personal en sus comentarios. Revise nuestra Política de Privacidad.
#### The People of the State of New York, Respondent, v Thomas Torres, Appellant.

Judgment unanimously affirmed. Memorandum: Defendant was convicted of burglary in the third degree, criminal possession of stolen property in the second degree, grand larceny in the third degree and conspiracy in the fifth degree. We have reviewed each of the issues raised by defendant on appeal and none requires reversal.

Although a police officer’s testimony that one of the accomplices had implicated defendant constituted improper bolstering *(see, People v McClean,*69 NY2d 426, 428; *People v Davis,*44 NY2d 269, 277), the proof of defendant’s guilt is overwhelming and there is no significant probability that defendant would have been acquitted but for this error *(see, People v Crimmins,*36 NY2d 230, 242).

We also find that the testimony of defendant’s two accomplices was sufficiently corroborated by evidence from independent sources tending to connect defendant with the crime *(see,*CPL 60.22 [1]; *People v Moses,*63 NY2d 299). (Appeal from judgment of Orleans County Court, Miles, J. — criminal possession of stolen property, second degree, and other charges.) Present — Dillon, P. J., Callahan, Denman, Green and Pine, JJ.
ex10-21.htm


    
      
        
          

        

      

      EXHIBIT
10.21

       

    

    Thomas
L. Gallagher

     
 

    Riverside,
CT 06878

    (203)
561-3585 / tleogallagher@gmail.com

    


    November
25, 2009

    


    R. Scott
Tobin

    President
and General Counsel

    Health
Discovery Corporation

    2 East
Bryan Street, Suite 601

    Savannah,
GA 31401

    


    Dear
Scott:

    


    I am
pleased to submit to you this letter of appointment in which Health Discovery
Corporation (the “Company”) agrees to the initial terms of my employment with
the Company, as follows:

    


    Effective
on December 1, 2009, I will join the Company as a W-2 employee with the title of
“Managing Director, SVM Diversified Strategies” with responsibilities that
include, but are not limited to, executing new licensing opportunities for the
Company’s SVM technology in the non-medical space, leading the contemplated New
York office of the Company if and when established, and other related duties,
while reporting to you and Steve Barnhill.

    


    The
Company will compensate me in the gross amount of $10,000 per month, plus an
agreed upon commission plan for licenses executed.  The Company and I
will work quickly to establish an appropriate commission agreement.

    


    In
addition, the Company agrees to provide standard medical benefits either through
a Company plan or through a payment or stipend for a plan of my choosing at a
cost not to exceed $1000 per month.  To the extent the Company
implements other employee benefits, I will be included in such
programs.

    


    If the
foregoing meets with your approval, please sign the acknowledgement below and
return a copy to my attention at your earliest convenience.

    


    Very best
regards,

    


    /s/
Thomas L. Gallagher

    


    Thomas L.
Gallagher

    


    The
foregoing is agreed and acknowledged by Health Discovery
Corporation

    


    


    By:  /s/
R. Scott Tobin

    Name:  R.
Scott Tobin

    Title:    President
and General Counsel

    Authorized
Representative